Log In
    Company Data

    Salarius Pharmaceuticals

    Healthcare
    Biotechnology
    Advanced Market Data
    Ticker
    SLRX
    Current Price
    $0.458 0.64%
    Market Cap
    $2.2M
    Price Target
    Refer to Report
    Volume
    14.6K
    52wk Range
    $0.43 - $1.8694
    Advanced Market Data

    Overview

    Salarius Pharmaceuticals Inc is a biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Its lead compound Seclidemstat is in clinical development for treating Ewing sarcoma.

    Other Considerations

    Unicycive Therapeutics Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Unicycive Therapeutics Inc.
    Unicycive Therapeutics Inc.
    UNCY (NSC)
    $1.08
    $1.09(-0.92%)
    40.6M
    69.9K
    $0.47 - $1.8227
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Cadrenal Therapeutics Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Cadrenal Therapeutics Inc.
    Cadrenal Therapeutics Inc.
    CVKD (NSC)
    $0.4434
    $0.44(0.66%)
    7.1M
    121.1K
    $0.36 - $3.14
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    YS Biopharma Co. Ltd.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    YS Biopharma Co. Ltd.
    YS Biopharma Co. Ltd.
    ys (NSC)
    126.1M
    $0.3503 - $1.78
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    MAIA Biotechnology Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    MAIA Biotechnology Inc.
    MAIA Biotechnology Inc.
    MAIA (AMX)
    $2.87
    $2.84(1.06%)
    57.4M
    87.5K
    $0.82 - $3.59
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Baudax Bio Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Baudax Bio Inc.
    Baudax Bio Inc.
    BXRX (Nasdaq)
    728.5K
    $0.0137 - $3.4699
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Eledon Pharmaceuticals
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Eledon Pharmaceuticals
    Eledon Pharmaceuticals
    ELDN (Nasdaq)
    $2.505
    $2.34(7.05%)
    62.2M
    139.3K
    $1.07 - $2.53
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Tonix Pharmaceuticals Holding Corp.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Tonix Pharmaceuticals Holding Corp.
    Tonix Pharmaceuticals Holding Corp.
    TNXP (Nasdaq)
    $0.1826
    $0.18(1.44%)
    17.4M
    968.2K
    $0.1202 - $2.1253
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    PDS Biotechnology Corporation
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    PDS Biotechnology Corporation
    PDS Biotechnology Corporation
    PDSB (Nasdaq)
    $3.5
    $3.54(-0.99%)
    128.4M
    583.1K
    $2.59 - $10.27
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Geovax Labs
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Geovax Labs
    Geovax Labs
    GOVX (Nasdaq)
    $1.72
    $1.7(1.18%)
    3.7M
    73.5K
    $1.38 - $11.5365
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Traws Pharma, Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Traws Pharma, Inc.
    Traws Pharma, Inc.
    TRAW (Nasdaq)
    $0.6574
    $0.65(1.12%)
    13.8M
    28.3K
    $0.5509 - $1.3299
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In